2016
DOI: 10.1310/hpj5107-599
|View full text |Cite
|
Sign up to set email alerts
|

Big Data: Implications for Health System Pharmacy

Abstract: Big Data refers to datasets that are so large and complex that traditional methods and hardware for collecting, sharing, and analyzing them are not possible. Big Data that is accurate leads to more confident decision making, improved operational efficiency, and reduced costs. The rapid growth of health care information results in Big Data around health services, treatments, and outcomes, and Big Data can be used to analyze the benefit of health system pharmacy services. The goal of this article is to provide a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0
4

Year Published

2018
2018
2020
2020

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(21 citation statements)
references
References 6 publications
0
17
0
4
Order By: Relevance
“…1,6,17,34 Another relevant advantage of the use of big data in pharmacoepidemiology and pharmacovigilance is the diversity of the data since medical records can be analyzed with information on hospitalization, outpatient consultations, drug prescriptions, and laboratory tests, besides opening up the possibility of continuous monitoring using intelligent electronic devices. 1,2,6 Due to the limitations of secondary data sources, their interpretation is associated with some important challenges, such as accumulation of estimation errors and spurious correlation. 3 These massive data flows must adjust to changing conditions all the time, so the algorithmic intelligence of digital epidemiology must be harnessed.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…1,6,17,34 Another relevant advantage of the use of big data in pharmacoepidemiology and pharmacovigilance is the diversity of the data since medical records can be analyzed with information on hospitalization, outpatient consultations, drug prescriptions, and laboratory tests, besides opening up the possibility of continuous monitoring using intelligent electronic devices. 1,2,6 Due to the limitations of secondary data sources, their interpretation is associated with some important challenges, such as accumulation of estimation errors and spurious correlation. 3 These massive data flows must adjust to changing conditions all the time, so the algorithmic intelligence of digital epidemiology must be harnessed.…”
Section: Discussionmentioning
confidence: 99%
“…This information, altogether, allows healthcare providers and government agencies to adjust the treatment plan by phone or applications, e-mails, or directly using the measurement device, thus promoting healthcare compliance. 2,3,5,17 Big data for drugs in the post-marketing phase…”
Section: Big Data In the Health Areamentioning
confidence: 99%
See 1 more Smart Citation
“…The well-known applications of Big Data today are the ability to use information to understand consumer demand and purchasing pattern for retail business. [3] With the expected growth of healthcare data volume to reach zettabytes (10 21 ), there is an increase in the awareness and innovation of garnering data for drug discovery, precision medicine and patient-centred pharmacy practices with personalised approaches to prevention, early detection, treatment and optimum management. [2] The examples of Big Data application are the electronic medical record (EMR) and clinical decision support such as the First Databank and the use of Big Data Analysis in predicting epidemic tropical diseases.…”
Section: Introductionmentioning
confidence: 99%
“…[2] The examples of Big Data application are the electronic medical record (EMR) and clinical decision support such as the First Databank and the use of Big Data Analysis in predicting epidemic tropical diseases. Although the growth in this area is still modest, it is undoubtedly a highly potential field to shift the paradigm of current pharmacy practices towards personalised care approaches and better pharmaceutical care [3][4].…”
Section: Introductionmentioning
confidence: 99%